Condensed Balance Sheets - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Current assets:
Cash	$ 1,074,065	$ 47,090
Prepaid expenses	1,126,472
Total current assets	2,200,537	47,090
Investments held in Trust Account	862,520,166
Deferred offering costs associated with initial public offering		282,875
Total Assets	864,720,703	329,965
Current liabilities:
Accounts payable	147,675	117,911
Accrued expenses	546,113	21,614
Franchise tax payable	97,584	609
Note payable – related party		170,000
Total current liabilities	791,372	310,134
Derivative warrant liabilities	52,707,710
Deferred underwriting commissions	30,187,500
Promissory note – related party	1,682,200
Total liabilities	85,368,782	310,134
Commitments and Contingencies
Class A common stock, $0.0001 par value; 77,435,192 and 0 shares subject to possible redemption at $10.00 per share at June 30, 2021 and December 31, 2020, respectively	774,351,920
Stockholders’ Equity:
Preferred stock, $0.0001 par value; 3,000,000 shares authorized; none issued and outstanding
Class A common stock, $0.0001 par value; 300,000,000 shares authorized; 8,814,808 and 0 shares issued and outstanding (excluding 77,435,192 and 0 shares subject to possible redemption) at June 30, 2021 and December 31, 2020, respectively	881
Class B common stock, $0.0001 par value; 30,000,000 shares authorized; 21,562,500 shares issued and outstanding at June 30, 2021 and December 31, 2020	2,156	2,156
Additional paid-in capital	20,871,512	22,844
Accumulated deficit	(15,874,548)	(5,169)
Total stockholders’ equity	5,000,001	19,831
Total Liabilities and Stockholders’ Equity	$ 864,720,703	$ 329,965